1. Home
  2. ADXN vs PBM Comparison

ADXN vs PBM Comparison

Compare ADXN & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADXN
  • PBM
  • Stock Information
  • Founded
  • ADXN 2002
  • PBM 1994
  • Country
  • ADXN Switzerland
  • PBM Canada
  • Employees
  • ADXN N/A
  • PBM N/A
  • Industry
  • ADXN Biotechnology: Pharmaceutical Preparations
  • PBM
  • Sector
  • ADXN Health Care
  • PBM
  • Exchange
  • ADXN Nasdaq
  • PBM NYSE
  • Market Cap
  • ADXN 8.0M
  • PBM 5.3M
  • IPO Year
  • ADXN N/A
  • PBM N/A
  • Fundamental
  • Price
  • ADXN $7.06
  • PBM $1.28
  • Analyst Decision
  • ADXN Strong Buy
  • PBM
  • Analyst Count
  • ADXN 1
  • PBM 0
  • Target Price
  • ADXN $30.00
  • PBM N/A
  • AVG Volume (30 Days)
  • ADXN 17.9K
  • PBM 386.4K
  • Earning Date
  • ADXN 03-24-2025
  • PBM 02-02-2025
  • Dividend Yield
  • ADXN N/A
  • PBM N/A
  • EPS Growth
  • ADXN N/A
  • PBM N/A
  • EPS
  • ADXN 0.06
  • PBM N/A
  • Revenue
  • ADXN $701,260.00
  • PBM N/A
  • Revenue This Year
  • ADXN N/A
  • PBM N/A
  • Revenue Next Year
  • ADXN N/A
  • PBM N/A
  • P/E Ratio
  • ADXN $0.92
  • PBM N/A
  • Revenue Growth
  • ADXN N/A
  • PBM N/A
  • 52 Week Low
  • ADXN $6.73
  • PBM $1.15
  • 52 Week High
  • ADXN $27.90
  • PBM $323.25
  • Technical
  • Relative Strength Index (RSI)
  • ADXN 42.98
  • PBM 36.81
  • Support Level
  • ADXN $6.73
  • PBM $1.15
  • Resistance Level
  • ADXN $7.90
  • PBM $1.59
  • Average True Range (ATR)
  • ADXN 0.51
  • PBM 0.20
  • MACD
  • ADXN -0.07
  • PBM 0.01
  • Stochastic Oscillator
  • ADXN 16.34
  • PBM 14.61

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Share on Social Networks: